Showing 331-340 of 20328 results for "".
The Centers for Disease Control’s Approach to Prevention of Diabetes
https://reachmd.com/programs/diabetes-discourse/the-centers-for-disease-controls-approach-to-prevention-of-diabetes/6009/The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating paDiabetic Sector Update
https://reachmd.com/programs/clinicians-roundtable/diabetic-sector-update/1643/Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Learn from David Kliff about the current and future medications and devices in the diabetic market.How Do I Advance DE&I in My Practice?
https://reachmd.com/topics/practice-development/how-do-i-advance-dei-in-my-practice/35212/The Increasing Role of the Pharmacist in Diabetes Care
https://reachmd.com/programs/diabetes-discourse/the-increasing-role-of-the-pharmacist-in-diabetes-care/5696/The management of diabetes is a sophisticated multi-disciplinary approach. There are multiple benefits to both the physician treating diabetes patients and the patients themselves by increasing the role of the pharmacist to provide a collaborative approach to care and placing the patient at the centDebating Diabetic Diets: Considering Keto for Patients with Diabetes
https://reachmd.com/programs/diabetes-discourse/considering-the-keto-diet/12588/What do we know of the efficacy and long-term safety of the keto diet for patients with diabetes?Why I Sold
https://reachmd.com/topics/practice-development/why-i-sold/35207/What key considerations led a prominent facial plastic surgeon to sell his practice?FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
https://reachmd.com/programs/FDA-Drug-Information-Updates/fda-confirms-leg-and-foot-amputation-risk-diabetes-medicine-canagliflozin/9587/The FDA concluded that the type 2 diabetes medicine canagliflozin causes an increased risk of leg and foot amputations.Diabetic Kidney Disease
https://reachmd.com/programs/clinicians-roundtable/diabetic-kidney-disease/1747/Kidney disease is on the rise especially amongst diabetics. In this segment Nephrologist, Dr. Robert Stanton talks about the incidence and treatment of diabetic kidney disease.Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
https://reachmd.com/programs/cme/advances-in-treatment-of-hypoparathyroidism-importance-of-genetic-testing-for-autosomal-dominant-hypocalcemia-type-1/36097/Tune in to explore ADH type 1 care! Learn to recognize clinical features, enhance your diagnosis with genetic testing, and assess emerging therapies.Microchimerism, Lupus, and Diabetes
https://reachmd.com/programs/clinicians-roundtable/microchimerism-lupus-and-diabetes/903/While the transfer and persistence of fetal cells into the maternal circulation is counter-intuitive, an even stranger occurrence is the reverse. Dr. Nelson discusses the evidence that maternal cells are transferring into the fetus. In the case of neonatal lupus it appears that maternal stem cells